Cargando…

Thioredoxin-Interacting Protein in Cancer and Diabetes

SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regul...

Descripción completa

Detalles Bibliográficos
Autor principal: Masutani, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125520/
https://www.ncbi.nlm.nih.gov/pubmed/34384271
http://dx.doi.org/10.1089/ars.2021.0038
_version_ 1784711954293587968
author Masutani, Hiroshi
author_facet Masutani, Hiroshi
author_sort Masutani, Hiroshi
collection PubMed
description SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regulated by multilayered mechanisms, including transcriptional regulation, microRNA, messenger RNA (mRNA) stabilization, and protein degradation. The Txnip-based connection between cancer and metabolism has been widely recognized. Meanwhile, new aspects are proposed for the mechanism of action of Txnip, including the regulation of RNA expression and autophagy. Arrestin domain containing 3 (ARRDC3), another α-arrestin protein, regulates endocytosis and signaling, whereas ARRDC1 and ARRDC4 regulate extracellular vesicle formation. CRITICAL ISSUES: The mechanism of action of Txnip is yet to be elucidated. The regulation of intracellular protein trafficking by arrestin family proteins has opened an emerging field of biology and medical research, which needs to be examined further. FUTURE DIRECTIONS: A fundamental understanding of the mechanism of action of Txnip and other arrestin family members needs to be explored in the future to combat diseases such as cancer and diabetes. Antioxid. Redox Signal. 36, 1001–1022.
format Online
Article
Text
id pubmed-9125520
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-91255202022-05-23 Thioredoxin-Interacting Protein in Cancer and Diabetes Masutani, Hiroshi Antioxid Redox Signal Article SIGNIFICANCE: Thioredoxin-interacting protein (Txnip) is an α-arrestin protein that acts as a cancer suppressor. Txnip is simultaneously a critical regulator of energy metabolism. Other alpha-arrestin proteins also play key roles in cell biology and cancer. RECENT ADVANCES: Txnip expression is regulated by multilayered mechanisms, including transcriptional regulation, microRNA, messenger RNA (mRNA) stabilization, and protein degradation. The Txnip-based connection between cancer and metabolism has been widely recognized. Meanwhile, new aspects are proposed for the mechanism of action of Txnip, including the regulation of RNA expression and autophagy. Arrestin domain containing 3 (ARRDC3), another α-arrestin protein, regulates endocytosis and signaling, whereas ARRDC1 and ARRDC4 regulate extracellular vesicle formation. CRITICAL ISSUES: The mechanism of action of Txnip is yet to be elucidated. The regulation of intracellular protein trafficking by arrestin family proteins has opened an emerging field of biology and medical research, which needs to be examined further. FUTURE DIRECTIONS: A fundamental understanding of the mechanism of action of Txnip and other arrestin family members needs to be explored in the future to combat diseases such as cancer and diabetes. Antioxid. Redox Signal. 36, 1001–1022. Mary Ann Liebert, Inc., publishers 2022-05-01 2022-05-06 /pmc/articles/PMC9125520/ /pubmed/34384271 http://dx.doi.org/10.1089/ars.2021.0038 Text en © Hiroshi Masutani, 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License [CC-BY-NC] (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.
spellingShingle Article
Masutani, Hiroshi
Thioredoxin-Interacting Protein in Cancer and Diabetes
title Thioredoxin-Interacting Protein in Cancer and Diabetes
title_full Thioredoxin-Interacting Protein in Cancer and Diabetes
title_fullStr Thioredoxin-Interacting Protein in Cancer and Diabetes
title_full_unstemmed Thioredoxin-Interacting Protein in Cancer and Diabetes
title_short Thioredoxin-Interacting Protein in Cancer and Diabetes
title_sort thioredoxin-interacting protein in cancer and diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125520/
https://www.ncbi.nlm.nih.gov/pubmed/34384271
http://dx.doi.org/10.1089/ars.2021.0038
work_keys_str_mv AT masutanihiroshi thioredoxininteractingproteinincanceranddiabetes